231 related articles for article (PubMed ID: 34156230)
1. Dimeric Tacrine(10)-hupyridone as a Multitarget-Directed Ligand To Treat Alzheimer's Disease.
Xuan Z; Gu X; Yan S; Xie Y; Zhou Y; Zhang H; Jin H; Hu S; Mak MSH; Zhou D; Keung Tsim KW; Carlier PR; Han Y; Cui W
ACS Chem Neurosci; 2021 Jul; 12(13):2462-2477. PubMed ID: 34156230
[TBL] [Abstract][Full Text] [Related]
2. Tacrine(10)-hupyridone, a dual-binding acetylcholinesterase inhibitor, potently attenuates scopolamine-induced impairments of cognition in mice.
Chen H; Xiang S; Huang L; Lin J; Hu S; Mak SH; Wang C; Wang Q; Cui W; Han Y
Metab Brain Dis; 2018 Aug; 33(4):1131-1139. PubMed ID: 29564727
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of novel tacrine-dipicolylamine dimers that are multiple-target-directed ligands with potential to treat Alzheimer's disease.
Zhang P; Wang Z; Mou C; Zou J; Xie Y; Liu Z; Benjamin Naman C; Mao Y; Wei J; Huang X; Dong J; Yang M; Wang N; Jin H; Liu F; Lin D; Liu H; Zhou F; He S; Zhang B; Cui W
Bioorg Chem; 2021 Nov; 116():105387. PubMed ID: 34628225
[TBL] [Abstract][Full Text] [Related]
4. Tacrine(10)-Hupyridone Prevents Post-operative Cognitive Dysfunction via the Activation of BDNF Pathway and the Inhibition of AChE in Aged Mice.
Chen H; Wu X; Gu X; Zhou Y; Ye L; Zhang K; Pan H; Wang J; Wei H; Zhu B; Naman CB; Mak S; Carlier PR; Cui W; Han Y
Front Cell Neurosci; 2018; 12():396. PubMed ID: 30483056
[TBL] [Abstract][Full Text] [Related]
5. Quinolinetrione-tacrine hybrids as multi-target-directed ligands against Alzheimer's disease.
Uliassi E; Bergamini C; Rizzardi N; Naldi M; Cores Á; Bartolini M; Carlos Menéndez J; Bolognesi ML
Bioorg Med Chem; 2023 Aug; 91():117419. PubMed ID: 37487339
[TBL] [Abstract][Full Text] [Related]
6. Novel Multitarget Directed Tacrine Hybrids as Anti-Alzheimer's Compounds Improved Synaptic Plasticity and Cognitive Impairment in APP/PS1 Transgenic Mice.
Li K; Jiang Y; Li G; Liu T; Yang Z
ACS Chem Neurosci; 2020 Dec; 11(24):4316-4328. PubMed ID: 33216529
[TBL] [Abstract][Full Text] [Related]
7. Tacrine-resveratrol fused hybrids as multi-target-directed ligands against Alzheimer's disease.
Jeřábek J; Uliassi E; Guidotti L; Korábečný J; Soukup O; Sepsova V; Hrabinova M; Kuča K; Bartolini M; Peña-Altamira LE; Petralla S; Monti B; Roberti M; Bolognesi ML
Eur J Med Chem; 2017 Feb; 127():250-262. PubMed ID: 28064079
[TBL] [Abstract][Full Text] [Related]
8. Novel Tacrine-Hydroxyphenylbenzimidazole hybrids as potential multitarget drug candidates for Alzheimer's disease.
Hiremathad A; Keri RS; Esteves AR; Cardoso SM; Chaves S; Santos MA
Eur J Med Chem; 2018 Mar; 148():255-267. PubMed ID: 29466775
[TBL] [Abstract][Full Text] [Related]
9. Multi-Target Drug Design of Anti-Alzheimer's Disease based on Tacrine.
Tian S; Huang Z; Meng Q; Liu Z
Mini Rev Med Chem; 2021; 21(15):2039-2064. PubMed ID: 33583371
[TBL] [Abstract][Full Text] [Related]
10. Cystamine-tacrine dimer: a new multi-target-directed ligand as potential therapeutic agent for Alzheimer's disease treatment.
Minarini A; Milelli A; Tumiatti V; Rosini M; Simoni E; Bolognesi ML; Andrisano V; Bartolini M; Motori E; Angeloni C; Hrelia S
Neuropharmacology; 2012 Feb; 62(2):997-1003. PubMed ID: 22032870
[TBL] [Abstract][Full Text] [Related]
11. New Multitarget Hybrids Bearing Tacrine and Phenylbenzothiazole Motifs as Potential Drug Candidates for Alzheimer's Disease.
Rajeshwari R; Chand K; Candeias E; Cardoso SM; Chaves S; Santos MA
Molecules; 2019 Feb; 24(3):. PubMed ID: 30736397
[TBL] [Abstract][Full Text] [Related]
12. Recent Developments in Tacrine-based Hybrids as a Therapeutic Option for Alzheimer's Disease.
Yamali C; Donmez S
Mini Rev Med Chem; 2023; 23(7):869-880. PubMed ID: 36464869
[TBL] [Abstract][Full Text] [Related]
13. Tacrine-hydroxamate derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation.
Xu A; He F; Zhang X; Li X; Ran Y; Wei C; James Chou C; Zhang R; Wu J
Bioorg Chem; 2020 May; 98():103721. PubMed ID: 32193030
[TBL] [Abstract][Full Text] [Related]
14. Tacrine derivatives and Alzheimer's disease.
Tumiatti V; Minarini A; Bolognesi ML; Milelli A; Rosini M; Melchiorre C
Curr Med Chem; 2010; 17(17):1825-38. PubMed ID: 20345341
[TBL] [Abstract][Full Text] [Related]
15. Management of oxidative stress and other pathologies in Alzheimer's disease.
Simunkova M; Alwasel SH; Alhazza IM; Jomova K; Kollar V; Rusko M; Valko M
Arch Toxicol; 2019 Sep; 93(9):2491-2513. PubMed ID: 31440798
[TBL] [Abstract][Full Text] [Related]
16. Dimeric bis (heptyl)-Cognitin Blocks Alzheimer's β-Amyloid Neurotoxicity Via the Inhibition of Aβ Fibrils Formation and Disaggregation of Preformed Fibrils.
Hu SQ; Wang R; Cui W; Mak SH; Li G; Hu YJ; Lee MY; Pang YP; Han YF
CNS Neurosci Ther; 2015 Dec; 21(12):953-61. PubMed ID: 26507365
[TBL] [Abstract][Full Text] [Related]
17. East meets West in the search for Alzheimer's therapeutics - novel dimeric inhibitors from tacrine and huperzine A.
Li WM; Kan KK; Carlier PR; Pang YP; Han YF
Curr Alzheimer Res; 2007 Sep; 4(4):386-96. PubMed ID: 17908041
[TBL] [Abstract][Full Text] [Related]
18. Novel multitarget-directed tacrine derivatives as potential candidates for the treatment of Alzheimer's disease.
Wu WY; Dai YC; Li NG; Dong ZX; Gu T; Shi ZH; Xue X; Tang YP; Duan JA
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):572-587. PubMed ID: 28133981
[TBL] [Abstract][Full Text] [Related]
19. Recent Developments on Multi-Target-Directed Tacrines for Alzheimer's Disease. I. The Pyranotacrines.
Romero A; Marco-Contelles J
Curr Top Med Chem; 2017; 17(31):3328-3335. PubMed ID: 29332586
[TBL] [Abstract][Full Text] [Related]
20. Protection against β-amyloid-induced synaptic and memory impairments via altering β-amyloid assembly by bis(heptyl)-cognitin.
Chang L; Cui W; Yang Y; Xu S; Zhou W; Fu H; Hu S; Mak S; Hu J; Wang Q; Ma VP; Choi TC; Ma ED; Tao L; Pang Y; Rowan MJ; Anwyl R; Han Y; Wang Q
Sci Rep; 2015 Jul; 5():10256. PubMed ID: 26194093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]